The main takeaways I picked up on:
HIV
- 9 completed Human Trials- 2 still running
- The examination of the data for the 'Treatment Experienced' trial is expected to be comment-able this year.
- Biotron is not interested in taking drugs through to registration without partnership.
- 9 years left on the 2007 patent
- Further protection is underway with a new patent application, (PCT), that has been already been filed for immunomodulation.
- More HIV drugs doing safety studies before end of year.
HCV
- Human trial early 2023
Covid
- The FDA Guided phase 2 trial is for the purpose of gathering data for future partners.
- Biotron is not interested in taking drugs through to registration without the aforementioned partnership.
- Aiming to do the Phase 2 this year, (if all goes smoothly).
- Phase 2 could be within or outside the USA.- If in USA it will be IND.
- If outside it will be IND Enabling, which means the same thing, just not physically taking place in the USA.
- Phase 3, after successful phase 2, to follow in 2023, but Biotron wishes to do that with a partner.
- Forums
- ASX - By Stock
- BIT
- Funding Structure
Funding Structure, page-127
-
- There are more pages in this discussion • 27 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add BIT (ASX) to my watchlist
(20min delay)
|
|||||
Last
2.0¢ |
Change
0.001(5.26%) |
Mkt cap ! $18.04M |
Open | High | Low | Value | Volume |
1.9¢ | 2.0¢ | 1.9¢ | $6.191K | 315.2K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
4 | 963297 | 1.9¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
2.0¢ | 1734532 | 5 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
4 | 963297 | 0.019 |
10 | 1774771 | 0.018 |
8 | 927388 | 0.017 |
12 | 3734154 | 0.016 |
9 | 1155000 | 0.015 |
Price($) | Vol. | No. |
---|---|---|
0.020 | 1734532 | 5 |
0.021 | 605263 | 2 |
0.022 | 997769 | 4 |
0.023 | 1449422 | 4 |
0.024 | 153949 | 2 |
Last trade - 16.10pm 02/10/2024 (20 minute delay) ? |
Featured News
BIT (ASX) Chart |